doValue S.p.A. (LON:0RTI)
London · Delayed Price · Currency is GBP · Price in EUR | Market Cap | 401.67M +17.2% |
| Revenue (ttm) | 483.84M +8.6% |
| Net Income | -15.27M |
| EPS | -0.08 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 9.24 |
| Dividend | 0.08 (3.81%) |
| Ex-Dividend Date | May 18, 2026 |
| Volume | 3,000 |
| Open | 2.484 |
| Previous Close | 2.330 |
| Day's Range | 2.484 - 2.484 |
| 52-Week Range | 1.957 - 3.262 |
| Beta | 1.43 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 5, 2026 |
About doValue
doValue S.p.A. engages in the management of non-performing loans (NLP), unlikely to pay (UTP), early arrears, and performing loans for banks and investors in Italy, Spain, Greece, and Cyprus. The company offers NPL servicing, including administration, management, and recovery of loans utilizing in court and out-of-court recovery processes for and on behalf of third parties for portfolios mainly consisting in non-performing loans; and real estate servicing, such as real estate collateral management, real estate development, and property manageme... [Read more]
News
doValue Slides: Investor presentation
doValue has posted slides in relation to its latest quarterly earnings report, which was published on May 21, 2026.
doValue Earnings Call Transcript: Q1 2026
Q1 2026 results were in line with internal phasing, with revenue at EUR 120 million and EBITDA margin at 29%. coeo, acquired in April, is outperforming expectations and will drive growth and diversification from Q2. Full-year guidance and dividend confirmed, with strong liquidity and leverage under control.
doValue Earnings release: Q1 2026
doValue released its Q1 2026 earnings on May 15, 2026, summarizing the period's financial results.
doValue Slides: Q1 2026
doValue has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 15, 2026.
doValue Quarterly report: Q1 2026
doValue has published its Q1 2026 quarterly earnings report on May 15, 2026.
doValue Earnings Call Transcript: Q4 2025
Met or exceeded all 2025 business plan targets, with strong revenue and EBITDA growth, robust cash flow, and successful M&A execution. Outlook for 2026 remains positive, with a strong pipeline, high dividend payout, and continued focus on technology and market expansion.
doValue Annual report: Q4 2025
doValue has published its Q4 2025 annual report on February 27, 2026.
doValue Earnings release: Q4 2025
doValue released its Q4 2025 earnings on February 27, 2026, summarizing the period's financial results.
doValue Slides: Q4 2025
doValue has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 27, 2026.
doValue Earnings Call Transcript: Q3 2025
Solid nine-month results with 29% revenue growth and 43% EBITDA ex NRI increase, driven by non-NPL revenue and successful integration of Gardant. New business intake surpassed targets, and a EUR 350 million bond issuance secured future financing.
doValue Quarterly report: Q3 2025
doValue has published its Q3 2025 quarterly earnings report on November 12, 2025.
doValue Earnings release: Q3 2025
doValue released its Q3 2025 earnings on November 12, 2025, summarizing the period's financial results.
doValue Slides: Q3 2025
doValue has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 12, 2025.
doValue Earnings Call Transcript: Q2 2025
Record H1 results with 32% revenue growth, 47% EBITDA increase, and strong cash flow. Non-NPL and value-added services drove diversification, while the coeo acquisition is set to further enhance digital capabilities and growth. Guidance and leverage targets reaffirmed.
doValue Earnings release: Q2 2025
doValue released its Q2 2025 earnings on August 7, 2025, summarizing the period's financial results.
doValue Slides: Q2 2025
doValue has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 7, 2025.
doValue Quarterly report: Q2 2025
doValue has published its Q2 2025 quarterly earnings report on August 7, 2025.